NGL Fine-Chem Limited has informed the Exchange about Credit Rating- Revision
NGLFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NGL Fine-Chem Limited has received a credit rating revision from CRISIL, with a long-term rating of CRISIL BBB+ and a Negative outlook. CRISIL BBB+ indicates an adequate degree of safety regarding timely servicing of financial obligations, but the Negative outlook signals that the rating may be downgraded if certain conditions deteriorate. The company has shared this update with both BSE and NSE as required under SEBI disclosure norms.
The Negative outlook on an already mid-tier investment-grade rating may concern investors, as it raises the possibility of a future downgrade. This could modestly increase borrowing costs and may weigh on sentiment, though the rating itself remains investment grade.